# Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders

> **NCT00153543** · PHASE1 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 86 (actual)

## Conditions studied

- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** PCV7 + PPV23, 2 months
- **BIOLOGICAL:** PCV7 + PPV23, 6 months

## Key facts

- **NCT ID:** NCT00153543
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2024-10-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00153543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00153543, "Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00153543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*